Application Domains

Radiotherapy for cancer treatment

With 20 million new cancer cases and 10 million deaths per year, cancer is a major global health challenge, ranking as the second leading cause of death. The future looks alarming, with a predicted 77% increase in global cancer cases, surpassing 35 million by 2050. This rise is influenced by aging population, growth, and increased exposition to risk factors such as tobacco, alcohol, obesity, and air pollution. 

Dealing with cancer is a top priority globally. Alongside surgery, chemotherapy, and immunotherapy, radiotherapy is a key player in cancer treatment, known for being cost-effective.

In the last decade, improvements in precise treatment and imaging have enhanced radiotherapy, reducing undesired side effects. This progress has led to more patients living longer, either cancer-free or with better control over the disease and better quality of life. 

As of 2024, the Radiotherapy Market is valued at USD 10.18 billion, and it’s expected to reach USD 12.51 billion by 2029, growing at a rate of 4.20% annually [Source: Mordor Intelligence]. This highlights the ongoing importance and expanding role of radiotherapy in the ever-changing landscape of cancer treatment. 

Particle accelerators for radiotherapy

Radiotherapy for cancer treatment is based on the use of a Linear Accelerator (a linac). This machine speeds up electrons to deliver X-ray or electron beams to a patient’s tumour and destroy the cancerous cells. The acceleration in these radiofrequency linacs is produced by means of an electromagnetic field, which is injected in the accelerator and maintained throughout the treatment. 

In recent years, FLASH radiotherapy has been attracting great interest and is expected to develop and spread in the close future. This new strategy for treating tumours with an ultra-high dose rate provides the great advantage of reduced damage to healthy tissue in comparison with conventional radiotherapy. Flash radiotherapy is also administered by means of particle accelerators. 

At ALTAM Systems, we have developed an innovative digital RF control system that allows automatic tuning, operation, feedback and control of the medical accelerator, leading to precise and effective cancer treatment. We partner with top radiotherapy system manufacturers to develop easy-to-integrate systems that not only speed up the process but also guarantee top-notch performance throughout. 

Our turnkey Magnetron AFC system is integrated in linear accelerators for radiotherapy developed by one of our partners.

Medical Imaging

Linear accelerators are also being increasingly used to produce radioisotopes for medicine imaging. 

Our ATT001 Digital RF Controller is integrated in linear accelerators for radioisotopes production manufactured by one of our partners.